{"id":"W3215258031","doi":"10.3390/curroncol28060408","title":"Examining Treatment Patterns and Real-World Outcomes in Chronic Lymphocytic Leukemia Using Administrative Data in Ontario","year":2021,"lang":"en","type":"article","venue":"Current Oncology","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"ca_institutions":"Ottawa Hospital; AstraZeneca (Canada); Sunnybrook Health Science Centre","funders":"AstraZeneca; Government of Ontario; Institute for Clinical Evaluative Sciences; Cancer Care Ontario; Canadian Institutes of Health Research; AstraZeneca Canada","keywords":"Chemoimmunotherapy; Medicine; Obinutuzumab; Fludarabine; Chlorambucil; Chronic lymphocytic leukemia; Ibrutinib; Cancer registry; Alemtuzumab; Rituximab; Internal medicine; Cyclophosphamide; Population; Cohort; Oncology; Retrospective cohort study; Bendamustine; Cancer; Family medicine; Leukemia; Chemotherapy; Lymphoma; Environmental health; Transplantation","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":true,"about_ca":true,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0003739051,0.0002894656,0.0008995385,0.0003290425,0.00004694283,0.00002842461,0.0001993832,0.0001500344,0.0002702357],"category_scores_gemma":[0.0001853454,0.000257546,0.0000445001,0.0003380391,0.0001546337,0.0001386295,0.000493823,0.000433126,0.00001221291],"about_ca_system_candidate":true,"about_ca_system_consensus":true,"about_ca_system_score_codex":0.4714453,"about_ca_system_score_gemma":0.1761948,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.2757043,"about_ca_topic_score_gemma":0.9163622,"domain_scores_codex":[0.9973423,0.0002429625,0.0006099048,0.0008665904,0.0002861186,0.0006520845],"domain_scores_gemma":[0.998119,0.0006054805,0.000119243,0.0008802476,0.00005974929,0.0002163104],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0002231823,0.0003406275,0.966489,0.0002179376,0.0001153131,0.004741807,0.002077702,0.00009754329,0.0003168681,0.0000615906,0.00003750407,0.02528095],"study_design_scores_gemma":[0.05750111,0.001818341,0.8643246,0.001038892,0.0002185138,0.0009052057,0.001308763,0.06175874,0.000708583,0.00004387824,0.009950183,0.0004231445],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.996265,0.00105717,0.0000182978,0.00008384381,0.0003731852,0.0005605352,0.00002974342,0.00002296069,0.001589248],"genre_scores_gemma":[0.9971121,0.001024824,0.0003158735,0.00004326971,0.0001212541,0.00005844014,0.000323798,0.00002811994,0.0009723103],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.6406578,"threshold_uncertainty_score":0.9999877,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.4472185385922062,"score_gpt":0.4972992301964138,"score_spread":0.05008069160420753,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}